PL1824493T3 - Zawiesina zawierająca meloksykam do podawania doustnego - Google Patents

Zawiesina zawierająca meloksykam do podawania doustnego

Info

Publication number
PL1824493T3
PL1824493T3 PL05850431T PL05850431T PL1824493T3 PL 1824493 T3 PL1824493 T3 PL 1824493T3 PL 05850431 T PL05850431 T PL 05850431T PL 05850431 T PL05850431 T PL 05850431T PL 1824493 T3 PL1824493 T3 PL 1824493T3
Authority
PL
Poland
Prior art keywords
meloxicam
oral suspension
pain
acute
preparation
Prior art date
Application number
PL05850431T
Other languages
English (en)
Inventor
Caspar Peter Elisabeth Biesmans
Spiegeleer Bart De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929998&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1824493(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1824493T3 publication Critical patent/PL1824493T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PL05850431T 2004-12-06 2005-12-02 Zawiesina zawierająca meloksykam do podawania doustnego PL1824493T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04106318 2004-12-06
EP05850431A EP1824493B1 (en) 2004-12-06 2005-12-02 Oral suspension comprising meloxicam
PCT/EP2005/056419 WO2006061351A1 (en) 2004-12-06 2005-12-02 Oral suspension comprising meloxicam

Publications (1)

Publication Number Publication Date
PL1824493T3 true PL1824493T3 (pl) 2009-01-30

Family

ID=34929998

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05850431T PL1824493T3 (pl) 2004-12-06 2005-12-02 Zawiesina zawierająca meloksykam do podawania doustnego

Country Status (14)

Country Link
US (1) US7705000B2 (pl)
EP (1) EP1824493B1 (pl)
JP (1) JP2008523024A (pl)
AT (1) ATE404206T1 (pl)
AU (1) AU2005313365A1 (pl)
CA (1) CA2586288A1 (pl)
DE (1) DE602005009016D1 (pl)
DK (1) DK1824493T3 (pl)
ES (1) ES2313452T3 (pl)
NO (1) NO20073419L (pl)
PL (1) PL1824493T3 (pl)
PT (1) PT1824493E (pl)
TW (1) TW200635598A (pl)
WO (1) WO2006061351A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2007135362A2 (en) * 2006-05-19 2007-11-29 Norbrook Laboratories Limited Stable aqueous suspension having palatable taste
GB2438287A (en) * 2006-05-19 2007-11-21 Norbrook Lab Ltd Stable aqueous suspension
WO2008009664A2 (en) * 2006-07-19 2008-01-24 Boehringer Ingelheim International Gmbh Treatment of pain
FR2911506B1 (fr) * 2007-01-18 2009-07-03 Ceva Sante Animale Sa Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees
US8999395B2 (en) 2007-02-09 2015-04-07 Ceva Sante Animale Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions
US20150231156A1 (en) * 2007-11-13 2015-08-20 Meritage Pharma, Inc. Corticosteroid compositions
US20110212948A1 (en) * 2008-09-05 2011-09-01 Giuseppe Pippia Treatment of neonate foals with meloxicam
JP5559339B2 (ja) * 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
GB201006218D0 (en) * 2010-04-14 2010-06-02 Ayanda As Composition
GB201117858D0 (en) * 2011-10-17 2011-11-30 Norbrook Lab Ltd Paste
PL239019B1 (pl) * 2017-07-14 2021-10-25 Aflofarm Farm Polska Spolka Z Ograniczona Odpowiedzialnoscia Kompozycja farmaceutyczna w postaci wodnego roztworu, korzystnie syropu, zawierająca pranobeks inozyny oraz glukonianu cynku oraz jej sposób otrzymywania
US20200360268A1 (en) * 2017-08-24 2020-11-19 Jiangsu Hengrui Medicine Co., Ltd. Injectable pharmaceutical composition containing meloxicam, and preparation method therefor
JP7374501B2 (ja) * 2018-05-11 2023-11-07 南京清普生物科技有限公司 メロキシカム組成物、製剤及びその製造方法と応用
KR20210021348A (ko) * 2018-06-15 2021-02-25 얀센 파마슈티카 엔.브이. 이브루티닙을 포함하는 제형/조성물
GB2585825B (en) * 2019-07-09 2023-03-22 Lexon Uk Holdings Ltd Suspending vehicle formulation
KR102530032B1 (ko) 2019-09-18 2023-05-09 정원구 반려동물용 현탁액 조성물 및 이의 제조방법
CN113143863A (zh) * 2020-01-22 2021-07-23 浙江贝灵生物医药有限公司 一种口服溶媒组合物及其制备方法与应用
CN112587497A (zh) * 2020-12-25 2021-04-02 苏州中化药品工业有限公司 一种美洛昔康混悬液胶囊剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
ZA987800B (en) 1997-08-27 1999-06-09 Hexal Ag Pharmaceutical composition of meloxicam
EP0945134A1 (de) 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
EP0945131A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Perorale Wirkstoff-Suspension
WO1999059634A1 (fr) 1998-05-15 1999-11-25 Wakamoto Pharmaceutical Co., Ltd. Gouttes oculaires anti-inflammatoires
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
EP1411900B2 (en) * 2001-06-01 2013-12-04 Pozen, Inc. PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
JP2004131495A (ja) * 2002-09-17 2004-04-30 Nippon Boehringer Ingelheim Co Ltd 非ステロイド系抗炎症剤の局所送達用医薬組成物
US20050095299A1 (en) * 2003-10-30 2005-05-05 Wynn David W. Controlled release analgesic suspensions

Also Published As

Publication number Publication date
ES2313452T3 (es) 2009-03-01
WO2006061351A1 (en) 2006-06-15
DK1824493T3 (da) 2008-12-08
AU2005313365A1 (en) 2006-06-15
US20090221563A1 (en) 2009-09-03
CA2586288A1 (en) 2006-06-15
EP1824493A1 (en) 2007-08-29
ATE404206T1 (de) 2008-08-15
NO20073419L (no) 2007-07-03
PT1824493E (pt) 2008-11-18
TW200635598A (en) 2006-10-16
EP1824493B1 (en) 2008-08-13
DE602005009016D1 (de) 2008-09-25
JP2008523024A (ja) 2008-07-03
US7705000B2 (en) 2010-04-27

Similar Documents

Publication Publication Date Title
PL1824493T3 (pl) Zawiesina zawierająca meloksykam do podawania doustnego
MX2007005870A (es) Composiciones que comprenden derivados de escilo-inositol y metodos para tratar trastornos de agregacion de proteinas.
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
WO2004075832A3 (en) Methods and compositions for the treatment of chronic pain using dhea and derivatives thereof
HK1108442A1 (en) Rapamcyin analogues and the uses thereof in the treatment of neurological, proliferative and inflammatory disorders
WO2006119958A3 (en) Use of flibanserin in the treatment of chronic pain
ZA200807879B (en) Use of bifidobacterium longum for the prevention and treatment of inflammation
IL178775A (en) Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy
IL182222A0 (en) Treatment of bipolar disorders and associated symptoms
WO2005115547A3 (en) Myricitrin compounds for sleeping disorders
WO2006122123A3 (en) Methods of alleviating disorders and their associated pain
TW200509896A (en) Analeptic and drug combinations
TWI372047B (en) Topical pain relief compositions of n,2,3-trimethyl-2-isopropylbutamide and methods for using the same
ZA200400313B (en) Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine.
WO2005113814A3 (en) Biomarkers of chronic pelvic pain syndrome
CA115335S (en) Massage chair
IL179636A0 (en) Combination therapy with radiolabeled anti-cd20 antibody in the treatment of b-cell lymphoma
CA118871S (en) Bicycle brake pad
CA115340S (en) Massage chair
CA115336S (en) Massage chair
WO2010129788A3 (en) Uses of cationic hydroxythylcellulose in oral ingestion forms, and prevention and treatment of metabolic disorders
WO2009108297A3 (en) Combination therapy for treatment of bone and mineral disorders for patients with impaired renal function
CA115333S (en) Massage chair
MXPA04000418A (es) Tratamiento de dolor cronico con 3-heterocicloxi- y -cicloalquiloxi-3-fenilpropanaminas.
CA115337S (en) Massage chair